
<div id="jpedal" style="overflow: hidden; position: relative; width: 893px; height: 1196px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_4{left:58px;top:103px;word-spacing:6.3px;}
#t2_4{left:58px;top:121px;word-spacing:5.7px;}
#t3_4{left:58px;top:140px;word-spacing:5.6px;}
#t4_4{left:76px;top:158px;word-spacing:6.8px;}
#t5_4{left:58px;top:176px;word-spacing:26.3px;}
#t6_4{left:58px;top:195px;word-spacing:5.7px;}
#t7_4{left:58px;top:213px;word-spacing:1.8px;}
#t8_4{left:58px;top:231px;word-spacing:17.5px;}
#t9_4{left:58px;top:249px;word-spacing:-1.9px;}
#ta_4{left:58px;top:268px;letter-spacing:0.1px;word-spacing:4.4px;}
#tb_4{left:199px;top:266px;}
#tc_4{left:216px;top:268px;letter-spacing:0.1px;word-spacing:4.5px;}
#td_4{left:58px;top:286px;word-spacing:11.1px;}
#te_4{left:58px;top:304px;letter-spacing:0.1px;word-spacing:-2.1px;}
#tf_4{left:58px;top:322px;word-spacing:7.4px;}
#tg_4{left:58px;top:341px;word-spacing:3.3px;}
#th_4{left:334px;top:339px;}
#ti_4{left:76px;top:359px;letter-spacing:0.1px;}
#tj_4{left:201px;top:359px;letter-spacing:0.1px;}
#tk_4{left:252px;top:359px;}
#tl_4{left:276px;top:359px;letter-spacing:0.1px;}
#tm_4{left:418px;top:359px;}
#tn_4{left:58px;top:377px;word-spacing:22.1px;}
#to_4{left:58px;top:395px;word-spacing:12px;}
#tp_4{left:58px;top:414px;word-spacing:4.6px;}
#tq_4{left:58px;top:432px;word-spacing:4.2px;}
#tr_4{left:276px;top:430px;}
#ts_4{left:282px;top:430px;}
#tt_4{left:291px;top:430px;}
#tu_4{left:308px;top:432px;word-spacing:4.1px;}
#tv_4{left:58px;top:450px;word-spacing:14.2px;}
#tw_4{left:58px;top:469px;letter-spacing:0.1px;word-spacing:11.3px;}
#tx_4{left:242px;top:467px;}
#ty_4{left:261px;top:469px;word-spacing:11.5px;}
#tz_4{left:58px;top:487px;word-spacing:15.2px;}
#t10_4{left:58px;top:505px;letter-spacing:0.1px;word-spacing:17.9px;}
#t11_4{left:58px;top:523px;letter-spacing:0.1px;word-spacing:11.5px;}
#t12_4{left:58px;top:542px;letter-spacing:0.1px;word-spacing:2.5px;}
#t13_4{left:58px;top:560px;word-spacing:3.8px;}
#t14_4{left:144px;top:558px;}
#t15_4{left:161px;top:560px;word-spacing:3.9px;}
#t16_4{left:58px;top:578px;word-spacing:12.7px;}
#t17_4{left:58px;top:596px;letter-spacing:0.1px;word-spacing:6.1px;}
#t18_4{left:232px;top:595px;}
#t19_4{left:244px;top:596px;word-spacing:6.2px;}
#t1a_4{left:58px;top:615px;word-spacing:3.1px;}
#t1b_4{left:58px;top:633px;word-spacing:0.7px;}
#t1c_4{left:58px;top:651px;word-spacing:12.2px;}
#t1d_4{left:58px;top:669px;word-spacing:12.8px;}
#t1e_4{left:58px;top:688px;letter-spacing:0.1px;}
#t1f_4{left:100px;top:686px;}
#t1g_4{left:115px;top:688px;word-spacing:19.2px;}
#t1h_4{left:58px;top:706px;word-spacing:5.2px;}
#t1i_4{left:76px;top:724px;word-spacing:12.8px;}
#t1j_4{left:58px;top:742px;word-spacing:12px;}
#t1k_4{left:58px;top:761px;word-spacing:19.8px;}
#t1l_4{left:58px;top:779px;letter-spacing:0.1px;word-spacing:5.9px;}
#t1m_4{left:264px;top:777px;}
#t1n_4{left:270px;top:777px;}
#t1o_4{left:279px;top:777px;}
#t1p_4{left:291px;top:779px;word-spacing:6.1px;}
#t1q_4{left:58px;top:797px;word-spacing:8.5px;}
#t1r_4{left:58px;top:815px;letter-spacing:0.1px;word-spacing:-0.1px;}
#t1s_4{left:58px;top:834px;word-spacing:2.1px;}
#t1t_4{left:58px;top:852px;word-spacing:10.4px;}
#t1u_4{left:369px;top:850px;}
#t1v_4{left:381px;top:852px;letter-spacing:0.1px;}
#t1w_4{left:58px;top:870px;word-spacing:7px;}
#t1x_4{left:58px;top:889px;letter-spacing:0.1px;word-spacing:8.2px;}
#t1y_4{left:58px;top:907px;word-spacing:6.6px;}
#t1z_4{left:58px;top:925px;letter-spacing:0.1px;word-spacing:24.2px;}
#t20_4{left:58px;top:943px;word-spacing:30.9px;}
#t21_4{left:58px;top:962px;letter-spacing:0.1px;word-spacing:14px;}
#t22_4{left:375px;top:962px;word-spacing:14.3px;}
#t23_4{left:58px;top:980px;word-spacing:16.2px;}
#t24_4{left:58px;top:998px;word-spacing:23.2px;}
#t25_4{left:357px;top:996px;}
#t26_4{left:408px;top:998px;}
#t27_4{left:58px;top:1016px;letter-spacing:0.1px;word-spacing:14.1px;}
#t28_4{left:58px;top:1035px;word-spacing:5.1px;}
#t29_4{left:58px;top:1053px;word-spacing:10.6px;}
#t2a_4{left:58px;top:1071px;word-spacing:5.2px;}
#t2b_4{left:246px;top:1070px;}
#t2c_4{left:76px;top:1089px;word-spacing:4.1px;}
#t2d_4{left:58px;top:1108px;word-spacing:10.9px;}
#t2e_4{left:58px;top:1126px;letter-spacing:0.1px;word-spacing:31.7px;}
#t2f_4{left:460px;top:103px;word-spacing:30.3px;}
#t2g_4{left:460px;top:121px;word-spacing:25.9px;}
#t2h_4{left:460px;top:140px;word-spacing:8.2px;}
#t2i_4{left:460px;top:158px;word-spacing:3px;}
#t2j_4{left:460px;top:176px;word-spacing:13.9px;}
#t2k_4{left:460px;top:195px;letter-spacing:0.1px;word-spacing:14px;}
#t2l_4{left:460px;top:213px;word-spacing:1.9px;}
#t2m_4{left:460px;top:231px;word-spacing:-0.5px;}
#t2n_4{left:460px;top:249px;word-spacing:6.5px;}
#t2o_4{left:649px;top:248px;}
#t2p_4{left:683px;top:249px;word-spacing:6.4px;}
#t2q_4{left:460px;top:268px;word-spacing:17.1px;}
#t2r_4{left:460px;top:286px;word-spacing:16.1px;}
#t2s_4{left:460px;top:304px;word-spacing:4.9px;}
#t2t_4{left:460px;top:322px;word-spacing:27.5px;}
#t2u_4{left:648px;top:321px;}
#t2v_4{left:671px;top:322px;letter-spacing:0.1px;word-spacing:27px;}
#t2w_4{left:460px;top:341px;word-spacing:14px;}
#t2x_4{left:460px;top:359px;word-spacing:22.1px;}
#t2y_4{left:460px;top:377px;word-spacing:0.8px;}
#t2z_4{left:577px;top:375px;}
#t30_4{left:594px;top:377px;word-spacing:1px;}
#t31_4{left:460px;top:395px;letter-spacing:0.1px;word-spacing:16.1px;}
#t32_4{left:460px;top:414px;word-spacing:18.6px;}
#t33_4{left:460px;top:432px;word-spacing:6.1px;}
#t34_4{left:460px;top:450px;word-spacing:11.6px;}
#t35_4{left:460px;top:469px;letter-spacing:0.1px;word-spacing:18.9px;}
#t36_4{left:460px;top:487px;word-spacing:4.3px;}
#t37_4{left:478px;top:505px;word-spacing:1.7px;}
#t38_4{left:460px;top:523px;word-spacing:2.8px;}
#t39_4{left:460px;top:542px;letter-spacing:0.1px;word-spacing:12.1px;}
#t3a_4{left:460px;top:560px;word-spacing:14px;}
#t3b_4{left:460px;top:578px;letter-spacing:0.1px;word-spacing:13.6px;}
#t3c_4{left:622px;top:576px;}
#t3d_4{left:642px;top:578px;word-spacing:13.1px;}
#t3e_4{left:460px;top:596px;word-spacing:24.3px;}
#t3f_4{left:460px;top:615px;letter-spacing:0.1px;word-spacing:13.1px;}
#t3g_4{left:460px;top:633px;letter-spacing:0.1px;word-spacing:12.3px;}
#t3h_4{left:460px;top:651px;word-spacing:4.3px;}
#t3i_4{left:460px;top:669px;word-spacing:8.2px;}
#t3j_4{left:460px;top:688px;word-spacing:9.1px;}
#t3k_4{left:460px;top:706px;letter-spacing:0.1px;}
#t3l_4{left:513px;top:704px;}
#t3m_4{left:536px;top:706px;word-spacing:28.5px;}
#t3n_4{left:460px;top:724px;letter-spacing:0.1px;word-spacing:37.8px;}
#t3o_4{left:460px;top:742px;word-spacing:17px;}
#t3p_4{left:460px;top:761px;letter-spacing:0.1px;word-spacing:12.8px;}
#t3q_4{left:460px;top:779px;word-spacing:20.2px;}
#t3r_4{left:460px;top:797px;letter-spacing:0.1px;word-spacing:32px;}
#t3s_4{left:712px;top:796px;}
#t3t_4{left:737px;top:797px;word-spacing:32px;}
#t3u_4{left:460px;top:815px;word-spacing:15.4px;}
#t3v_4{left:460px;top:834px;word-spacing:7.6px;}
#t3w_4{left:460px;top:852px;word-spacing:-0.1px;}
#t3x_4{left:460px;top:870px;word-spacing:5.1px;}
#t3y_4{left:675px;top:869px;}
#t3z_4{left:478px;top:889px;word-spacing:12.8px;}
#t40_4{left:460px;top:907px;word-spacing:1.9px;}
#t41_4{left:460px;top:925px;word-spacing:13px;}
#t42_4{left:460px;top:943px;word-spacing:5.2px;}
#t43_4{left:460px;top:962px;word-spacing:29.7px;}
#t44_4{left:460px;top:980px;letter-spacing:0.1px;}
#t45_4{left:514px;top:978px;}
#t46_4{left:539px;top:980px;word-spacing:35.7px;}
#t47_4{left:460px;top:998px;word-spacing:1.5px;}
#t48_4{left:460px;top:1016px;word-spacing:25.7px;}
#t49_4{left:567px;top:1016px;}
#t4a_4{left:590px;top:1016px;word-spacing:25.5px;}
#t4b_4{left:460px;top:1035px;}
#t4c_4{left:490px;top:1033px;}
#t4d_4{left:508px;top:1035px;word-spacing:6.9px;}
#t4e_4{left:791px;top:1033px;}
#t4f_4{left:809px;top:1035px;}
#t4g_4{left:460px;top:1053px;word-spacing:8.6px;}
#t4h_4{left:460px;top:1071px;word-spacing:1px;}
#t4i_4{left:460px;top:1089px;word-spacing:22.2px;}
#t4j_4{left:460px;top:1108px;word-spacing:1.9px;}
#t4k_4{left:460px;top:1126px;word-spacing:-0.9px;}
#t4l_4{left:58px;top:36px;}
#t4m_4{left:196px;top:36px;word-spacing:4.7px;}

.s4_4{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: BLDFFM-AdvPSSym4;
	color: rgb(0,0,0);
}

.s6_4{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: BLDFGP-AdvPSA35B4;
	color: rgb(0,0,0);
}

.s3_4{
	FONT-SIZE: 40.6px;
	FONT-FAMILY: BLDFFO-AdvPS44A44B4;
	color: rgb(0,0,0);
}

.s5_4{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: BLDFDE-AdvPSA35F4;
	color: rgb(0,0,0);
}

.s2_4{
	FONT-SIZE: 40.6px;
	FONT-FAMILY: BLDFEI-AdvPSNCS-R4;
	color: rgb(0,0,0);
}

.s1_4{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: BLDFEI-AdvPSNCS-R4;
	color: rgb(0,0,0);
}

.v1_4{
	-webkit-transform: scale(0.281, 0.25);
	-ms-transform: scale(0.281, 0.25);
	-moz-transform: scale(0.281, 0.25);
	-o-transform: scale(0.281, 0.25);
}

#form4_1{	border-style:none;	z-index:2;	position: absolute;	left:278px;	top:773px;	width:8px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_2{	border-style:none;	z-index:2;	position: absolute;	left:275px;	top:426px;	width:8px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_3{	border-style:none;	z-index:2;	position: absolute;	left:263px;	top:773px;	width:8px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_4{	border-style:none;	z-index:2;	position: absolute;	left:99px;	top:683px;	width:8px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_5{	border-style:none;	z-index:2;	position: absolute;	left:368px;	top:847px;	width:8px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_6{	border-style:none;	z-index:2;	position: absolute;	left:231px;	top:591px;	width:9px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_7{	border-style:none;	z-index:2;	position: absolute;	left:333px;	top:336px;	width:14px;	height:15px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_8{	border-style:none;	z-index:2;	position: absolute;	left:242px;	top:463px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_9{	border-style:none;	z-index:2;	position: absolute;	left:712px;	top:792px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_10{	border-style:none;	z-index:2;	position: absolute;	left:514px;	top:975px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_11{	border-style:none;	z-index:2;	position: absolute;	left:622px;	top:573px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_12{	border-style:none;	z-index:2;	position: absolute;	left:290px;	top:426px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_13{	border-style:none;	z-index:2;	position: absolute;	left:648px;	top:318px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_14{	border-style:none;	z-index:2;	position: absolute;	left:199px;	top:263px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_15{	border-style:none;	z-index:2;	position: absolute;	left:512px;	top:701px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_16{	border-style:none;	z-index:2;	position: absolute;	left:674px;	top:865px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_17{	border-style:none;	z-index:2;	position: absolute;	left:245px;	top:1067px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_18{	border-style:none;	z-index:2;	position: absolute;	left:144px;	top:555px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_19{	border-style:none;	z-index:2;	position: absolute;	left:790px;	top:1030px;	width:15px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_20{	border-style:none;	z-index:2;	position: absolute;	left:489px;	top:1030px;	width:15px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_21{	border-style:none;	z-index:2;	position: absolute;	left:576px;	top:371px;	width:15px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_22{	border-style:none;	z-index:2;	position: absolute;	left:649px;	top:245px;	width:29px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_23{	border-style:none;	z-index:2;	position: absolute;	left:356px;	top:993px;	width:43px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_24{	border-style:none;	z-index:2;	position: absolute;	left:656px;	top:106px;	width:57px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_25{	border-style:none;	z-index:2;	position: absolute;	left:239px;	top:963px;	width:138px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_26{	border-style:none;	z-index:2;	position: absolute;	left:281px;	top:361px;	width:138px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_27{	border-style:none;	z-index:2;	position: absolute;	left:63px;	top:963px;	width:165px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_28{	border-style:none;	z-index:2;	position: absolute;	left:75px;	top:361px;	width:187px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts4" type="text/css" >

@font-face {
	font-family: BLDFFO-AdvPS44A44B4;
	src: url("4/fonts/BLDFFO-AdvPS44A44B.woff") format("woff");
}

@font-face {
	font-family: BLDFEI-AdvPSNCS-R4;
	src: url("4/fonts/BLDFEI-AdvPSNCS-R.woff") format("woff");
}

@font-face {
	font-family: BLDFGP-AdvPSA35B4;
	src: url("4/fonts/BLDFGP-AdvPSA35B.woff") format("woff");
}

@font-face {
	font-family: BLDFDE-AdvPSA35F4;
	src: url("4/fonts/BLDFDE-AdvPSA35F.woff") format("woff");
}

@font-face {
	font-family: BLDFFM-AdvPSSym4;
	src: url("4/fonts/BLDFFM-AdvPSSym.woff") format("woff");
}

</style>
<div id="t1_4" class="t s1_4">using TTh in men with CaP. These results confrm</div>
<div id="t2_4" class="t s1_4">prior reports oF a low rate oF recurrent CaP in men</div>
<div id="t3_4" class="t s1_4">who receive TTh.</div>
<div id="t4_4" class="t s1_4">We observed a slight increase in PSA in men on</div>
<div id="t5_4" class="t s1_4">TTh with high risk CaP, consistent with prior</div>
<div id="t6_4" class="t s1_4">studies showing slight increases in PSA For several</div>
<div id="t7_4" class="t s1_4">months aFter TTh initiation in hypogonadal men. In</div>
<div id="t8_4" class="t s1_4">a randomized, controlled trial oF TTh in 44 men</div>
<div id="t9_4" class="t s1_4">Marks et al noted this PSA increase in the treatment</div>
<div id="ta_4" class="t s1_4">and placebo groups.</div>
<div id="tb_4" class="t v1_4 s2_4">14</div>
<div id="tc_4" class="t s1_4">In a study oF 75 hypogonadal</div>
<div id="td_4" class="t s1_4">men with or without PIN treated with TTh slight</div>
<div id="te_4" class="t s1_4">PSA increases were observed in the PIN positive and</div>
<div id="tf_4" class="t s1_4">negative groups with only 1 CaP case Found in the</div>
<div id="tg_4" class="t s1_4">PIN positive group aFter 1 year oF TTh.</div>
<div id="th_4" class="t v1_4 s2_4">15</div>
<div id="ti_4" class="t s1_4">Supplementary</div>
<div id="tj_4" class="t s1_4">table</div>
<div id="tk_4" class="t s1_4">2</div>
<div id="tl_4" class="t s1_4">(http://jurology.com/</div>
<div id="tm_4" class="t s1_4">)</div>
<div id="tn_4" class="t s1_4">shows the literature on TTh in men with CaP.</div>
<div id="to_4" class="t s1_4">Previous studies oF the eFfcacy and saFety oF TTh</div>
<div id="tp_4" class="t s1_4">aFter RT For CaP in a total oF 69 men demonstrated</div>
<div id="tq_4" class="t s1_4">no BCR and no PSA increases.</div>
<div id="tr_4" class="t v1_4 s2_4">8</div>
<div id="ts_4" class="t v1_4 s3_4">e</div>
<div id="tt_4" class="t v1_4 s2_4">11</div>
<div id="tu_4" class="t s1_4">In 2007 Sarosdy</div>
<div id="tv_4" class="t s1_4">evaluated 31 men with CaP treated with brachy-</div>
<div id="tw_4" class="t s1_4">therapy Followed by TTh.</div>
<div id="tx_4" class="t v1_4 s2_4">11</div>
<div id="ty_4" class="t s1_4">There was a transient</div>
<div id="tz_4" class="t s1_4">increase in PSA in 1 patient during a median oF</div>
<div id="t10_4" class="t s1_4">5 years. Subsequently Morales et al evaluated 5</div>
<div id="t11_4" class="t s1_4">hypogonadal men with localized CaP treated with</div>
<div id="t12_4" class="t s1_4">EBRT and TTh, and also Found a transient increase</div>
<div id="t13_4" class="t s1_4">in PSA in 1.</div>
<div id="t14_4" class="t v1_4 s2_4">10</div>
<div id="t15_4" class="t s1_4">Pastuszak et al evaluated a cohort oF</div>
<div id="t16_4" class="t s1_4">13 men with localized CaP treated with EBRT or</div>
<div id="t17_4" class="t s1_4">brachytherapy and TTh.</div>
<div id="t18_4" class="t v1_4 s2_4">8</div>
<div id="t19_4" class="t s1_4">The men were Followed a</div>
<div id="t1a_4" class="t s1_4">median oF 2.5 years and only 1 had a transient PSA</div>
<div id="t1b_4" class="t s1_4">increase. In 2014 Balbontin et al reported a series oF</div>
<div id="t1c_4" class="t s1_4">20 men with CaP treated with brachytherapy Fol-</div>
<div id="t1d_4" class="t s1_4">lowed by TTh who were Followed a median oF 2.5</div>
<div id="t1e_4" class="t s1_4">years.</div>
<div id="t1f_4" class="t v1_4 s2_4">9</div>
<div id="t1g_4" class="t s1_4">They observed a decrease in PSA in the</div>
<div id="t1h_4" class="t s1_4">cohort From 0.07 to 0.01 ng/ml.</div>
<div id="t1i_4" class="t s1_4">Studies in men treated with RP have similarly</div>
<div id="t1j_4" class="t s1_4">demonstrated low rates oF CaP recurrence or pro-</div>
<div id="t1k_4" class="t s1_4">gression with minimal changes in mean PSA at</div>
<div id="t1l_4" class="t s1_4">Followup as long as 12 years.</div>
<div id="t1m_4" class="t v1_4 s2_4">4</div>
<div id="t1n_4" class="t v1_4 s3_4">e</div>
<div id="t1o_4" class="t v1_4 s2_4">6</div>
<div id="t1p_4" class="t s1_4">A retrospective re-</div>
<div id="t1q_4" class="t s1_4">view oF 103 hypogonadal men on TTh and 49 non-</div>
<div id="t1r_4" class="t s1_4">hypogonadal men with a history oF CaP treated with</div>
<div id="t1s_4" class="t s1_4">RP showed a small, statistically signifcant increase</div>
<div id="t1t_4" class="t s1_4">in PSA in the hypogonadal cohort on TTh.</div>
<div id="t1u_4" class="t v1_4 s2_4">6</div>
<div id="t1v_4" class="t s1_4">There</div>
<div id="t1w_4" class="t s1_4">was lower BCR in that group during the 28-month</div>
<div id="t1x_4" class="t s1_4">Followup compared with that in an untreated com-</div>
<div id="t1y_4" class="t s1_4">parison group. Overall in men treated with RP the</div>
<div id="t1z_4" class="t s1_4">existing literature reveals that CaP recurrences</div>
<div id="t20_4" class="t s1_4">were reported in only 4 oF 177 patients (2%)</div>
<div id="t21_4" class="t s1_4">(supplementary table 2, http://jurology.com/</div>
<div id="t22_4" class="t s1_4">). This</div>
<div id="t23_4" class="t s1_4">value is lower than published rates oF 6% to 9%</div>
<div id="t24_4" class="t s1_4">3 years aFter RP and 14% at 5 years.</div>
<div id="t25_4" class="t v1_4 s2_4">4,5,7,16</div>
<div id="t26_4" class="t s1_4">In</div>
<div id="t27_4" class="t s1_4">addition, even in a study oF 13 hypogonadal men</div>
<div id="t28_4" class="t s1_4">with CaP who were on TTh and active surveillance</div>
<div id="t29_4" class="t s1_4">no clinical progression was observed during a me-</div>
<div id="t2a_4" class="t s1_4">dian 2.5 years oF Followup.</div>
<div id="t2b_4" class="t v1_4 s2_4">12</div>
<div id="t2c_4" class="t s1_4">In our cohort 6 oF 98 (6%) men met BCR criteria.</div>
<div id="t2d_4" class="t s1_4">Notably 3 men with suspected BCR originally un-</div>
<div id="t2e_4" class="t s1_4">derwent brachytherapy with PSA peaking and</div>
<div id="t2f_4" class="t s1_4">subsequently decreasing (table 2). Rather than</div>
<div id="t2g_4" class="t s1_4">representing BCR, this may have been a post-</div>
<div id="t2h_4" class="t s1_4">brachytherapy PSA bounce and was unlikely to be</div>
<div id="t2i_4" class="t s1_4">a direct eFFect oF TTh. When examining outcomes in</div>
<div id="t2j_4" class="t s1_4">the high risk subgroup, 2 oF 11 men (18.2%) met</div>
<div id="t2k_4" class="t s1_4">BCR criteria. Previously reported CaP recurrence</div>
<div id="t2l_4" class="t s1_4">rates Following RT in men who did not undergo TTh</div>
<div id="t2m_4" class="t s1_4">range From 13% to 65% with high risk disease in less</div>
<div id="t2n_4" class="t s1_4">than 10% oF these cohorts.</div>
<div id="t2o_4" class="t v1_4 s2_4">17,18</div>
<div id="t2p_4" class="t s1_4">ZeleFsky et al Found</div>
<div id="t2q_4" class="t s1_4">that For tumors treated with conFormal radiation</div>
<div id="t2r_4" class="t s1_4">5-year BCR was 35% to 65% among men with a</div>
<div id="t2s_4" class="t s1_4">Gleason sum oF greater than 6 depending on tumor</div>
<div id="t2t_4" class="t s1_4">stage and baseline PSA.</div>
<div id="t2u_4" class="t v1_4 s2_4">19</div>
<div id="t2v_4" class="t s1_4">Similarly ±ukunaga-</div>
<div id="t2w_4" class="t s1_4">Johnson et al reported 66% 5-year BCR aFter RT</div>
<div id="t2x_4" class="t s1_4">in patients with Gl 8-10 disease and 40% BCR</div>
<div id="t2y_4" class="t s1_4">2 years aFter RT.</div>
<div id="t2z_4" class="t v1_4 s2_4">20</div>
<div id="t30_4" class="t s1_4">It is reassuring that rates oF CaP</div>
<div id="t31_4" class="t s1_4">recurrence in the current study were lower than</div>
<div id="t32_4" class="t s1_4">reported recurrence rates aFter RT without TTh.</div>
<div id="t33_4" class="t s1_4">However, we cannot draw defnitive conclusions on</div>
<div id="t34_4" class="t s1_4">the saFety oF TTh in this setting due to the study</div>
<div id="t35_4" class="t s1_4">limited sample size, retrospective nature, overall</div>
<div id="t36_4" class="t s1_4">short Followup and absent eugonadal control group.</div>
<div id="t37_4" class="t s1_4">The long-standing concern regarding TTh in men</div>
<div id="t38_4" class="t s1_4">with CaP originated with the seminal 1941 study oF</div>
<div id="t39_4" class="t s1_4">Huggins and Hodges, which demonstrated regres-</div>
<div id="t3a_4" class="t s1_4">sion oF metastatic CaP Following castration or es-</div>
<div id="t3b_4" class="t s1_4">trogen administration.</div>
<div id="t3c_4" class="t v1_4 s2_4">21</div>
<div id="t3d_4" class="t s1_4">This led to the androgen</div>
<div id="t3e_4" class="t s1_4">dependent model oF CaP. Although it has been</div>
<div id="t3f_4" class="t s1_4">interpreted to suggest that increasing serum T is</div>
<div id="t3g_4" class="t s1_4">deleterious, this view is not supported by modern</div>
<div id="t3h_4" class="t s1_4">evidence. In a large prospective study in 3,886 men</div>
<div id="t3i_4" class="t s1_4">with CaP and 6,448 age matched controls the CaP</div>
<div id="t3j_4" class="t s1_4">risk was unrelated to the serum androgen concen-</div>
<div id="t3k_4" class="t s1_4">tration.</div>
<div id="t3l_4" class="t v1_4 s2_4">22</div>
<div id="t3m_4" class="t s1_4">In the placebo arm oF the REDUCE</div>
<div id="t3n_4" class="t s1_4">(Reduction by Dutasteride oF Prostate Cancer</div>
<div id="t3o_4" class="t s1_4">Events) trial in 3,255 men in which participants</div>
<div id="t3p_4" class="t s1_4">underwent prostate biopsies at years 2 and 4 the</div>
<div id="t3q_4" class="t s1_4">CaP risk was also unrelated to the serum T or</div>
<div id="t3r_4" class="t s1_4">dihydrotestosterone concentration.</div>
<div id="t3s_4" class="t v1_4 s2_4">23</div>
<div id="t3t_4" class="t s1_4">In a meta-</div>
<div id="t3u_4" class="t s1_4">analysis oF 22 randomized, placebo controlled tri-</div>
<div id="t3v_4" class="t s1_4">als in a total oF 2,351 men who were studied up to</div>
<div id="t3w_4" class="t s1_4">36 months the group on T were at no greater risk For</div>
<div id="t3x_4" class="t s1_4">CaP than the men on placebo.</div>
<div id="t3y_4" class="t v1_4 s2_4">24</div>
<div id="t3z_4" class="t s1_4">The apparent paradox between the prostate eF-</div>
<div id="t40_4" class="t s1_4">Fects oF ADT and the Failure to identiFy an increased</div>
<div id="t41_4" class="t s1_4">CaP risk in men with higher serum androgens is</div>
<div id="t42_4" class="t s1_4">explained by the saturation model, which describes</div>
<div id="t43_4" class="t s1_4">a fnite ability oF androgens to stimulate CaP</div>
<div id="t44_4" class="t s1_4">growth.</div>
<div id="t45_4" class="t v1_4 s2_4">25</div>
<div id="t46_4" class="t s1_4">The saturation point appears to be</div>
<div id="t47_4" class="t s1_4">approximately 250 ng/dl based on evidence From the</div>
<div id="t48_4" class="t s1_4">TriUS (Testim</div>
<div id="t49_4" class="t s4_4">Ò</div>
<div id="t4a_4" class="t s1_4">Registry in the United States)</div>
<div id="t4b_4" class="t s1_4">trial</div>
<div id="t4c_4" class="t v1_4 s2_4">26</div>
<div id="t4d_4" class="t s1_4">and a placebo controlled study oF T gel.</div>
<div id="t4e_4" class="t v1_4 s2_4">27</div>
<div id="t4f_4" class="t s1_4">In</div>
<div id="t4g_4" class="t s1_4">each study PSA increases were Found in men with</div>
<div id="t4h_4" class="t s1_4">baseline T less than 250 ng/dl but not in men with T</div>
<div id="t4i_4" class="t s1_4">greater than 250 ng/dl. A saturation curve was</div>
<div id="t4j_4" class="t s1_4">similarly Found by Rastrelli et al in their population</div>
<div id="t4k_4" class="t s1_4">oF 2,967 men in whom maximal PSA was achieved at</div>
<div id="t4l_4" class="t s5_4">1274</div>
<div id="t4m_4" class="t s6_4">TESTOSTERONE THERAPY AFTER RADIATION THERAPY FOR PROSTATE CANCER</div>

<form>
<input type="button"  tabindex="12"  id="form4_1" name="38 0 R"  pdfFieldName="38 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="5"  id="form4_2" name="31 0 R"  pdfFieldName="31 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="11"  id="form4_3" name="37 0 R"  pdfFieldName="37 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="10"  id="form4_4" name="36 0 R"  pdfFieldName="36 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="13"  id="form4_5" name="39 0 R"  pdfFieldName="39 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="9"  id="form4_6" name="35 0 R"  pdfFieldName="35 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="2"  id="form4_7" name="28 0 R"  pdfFieldName="28 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="7"  id="form4_8" name="33 0 R"  pdfFieldName="33 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="24"  id="form4_9" name="50 0 R"  pdfFieldName="50 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="26"  id="form4_10" name="52 0 R"  pdfFieldName="52 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="22"  id="form4_11" name="48 0 R"  pdfFieldName="48 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="6"  id="form4_12" name="32 0 R"  pdfFieldName="32 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="20"  id="form4_13" name="46 0 R"  pdfFieldName="46 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="1"  id="form4_14" name="27 0 R"  pdfFieldName="27 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="23"  id="form4_15" name="49 0 R"  pdfFieldName="49 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="25"  id="form4_16" name="51 0 R"  pdfFieldName="51 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="17"  id="form4_17" name="43 0 R"  pdfFieldName="43 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="8"  id="form4_18" name="34 0 R"  pdfFieldName="34 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="28"  id="form4_19" name="54 0 R"  pdfFieldName="54 0 R" onclick="window.location.href='6.html';" style="cursor:pointer;"  title="Page 6" />
<input type="button"  tabindex="27"  id="form4_20" name="53 0 R"  pdfFieldName="53 0 R" onclick="window.location.href='6.html';" style="cursor:pointer;"  title="Page 6" />
<input type="button"  tabindex="21"  id="form4_21" name="47 0 R"  pdfFieldName="47 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="19"  id="form4_22" name="45 0 R"  pdfFieldName="45 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="16"  id="form4_23" name="42 0 R"  pdfFieldName="42 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="18"  id="form4_24" name="44 0 R"  pdfFieldName="44 0 R" onclick="window.location.href='3.html';" style="cursor:pointer;"  title="Page 3" />
<input type="button"  tabindex="15"  id="form4_25" name="41 0 R"  pdfFieldName="41 0 R" onclick="window.open('http://jurology.com/','_blank');" style="cursor:pointer;" title="http://jurology.com/" />
<input type="button"  tabindex="4"  id="form4_26" name="30 0 R"  pdfFieldName="30 0 R" onclick="window.open('http://jurology.com/','_blank');" style="cursor:pointer;" title="http://jurology.com/" />
<input type="button"  tabindex="14"  id="form4_27" name="40 0 R"  pdfFieldName="40 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />
<input type="button"  tabindex="3"  id="form4_28" name="29 0 R"  pdfFieldName="29 0 R" onclick="window.location.href='index.html';" style="cursor:pointer;"  title="Page -1" />

</form>
<div id="pg4Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg4"><object width="893" height="1196" data="4/4.svg" type="image/svg+xml" id="pdf4" style="width:893px; height:1196px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 167;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_4");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
